Previous 10 | Next 10 |
Predictive Oncology (NASDAQ: POAI) , a knowledge-driven company focused on applying artificial intelligence (“AI”) to develop personalized cancer therapies, today announced that Pamela Bush, Ph.D., MBA will be joining the company’s leadership team as SVP of Strategic Sa...
EAGAN, Minn., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology , (POAI), a knowledge-driven company focused on applying artificial intelligence (AI) to develop personalized cancer therapies, today announced that Pamela Bush, Ph.D., MBA would be joining the company’s lead...
Predictive Oncology (NASDAQ:POAI) has acquired of zPREDICTA, a company pioneering tumor-specific in vitro 3D cell culture models for drug discovery and development. The acquisition adds a new anticipated revenue stream to Predictive Oncology. Based on zPREDICTA's historical operating res...
EAGAN, Minn., Dec. 01, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology , (POAI), a knowledge-driven company focused on applying artificial intelligence (AI) to develop personalized cancer therapies, today announced the acquisition of zPREDICTA , a company pioneering tumor-specific in v...
Predictive Oncology (NASDAQ:POAI): Q3 GAAP EPS of -$0.08 misses by $0.03. Revenue of $0.31M (-35.4% Y/Y) misses by $0.29M. Press Release For further details see: Predictive Oncology EPS misses by $0.03, misses on revenue
EAGAN, Minn., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Results from the third quarter show strong potential for future growth, said Predictive Oncology (Nasdaq: POAI) today, announcing financial results for the quarter ended September 30, 2021. All three of Predictive Oncology’s reportable ...
Predictive Oncology (NASDAQ: POAI) , an oncology and cancer research company using big data and machine learning to improve pharmaceutical development and predictive treatment outcomes, today announced the launch of a website that emphasizes its role in advancing its mission. According to t...
MINNEAPOLIS, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology , an oncology and cancer research company using big data and machine learning to improve pharmaceutical development and predictive treatment outcomes, launched a website today that emphasizes its role in advancing its mi...
Gainers: Elite Education Group International (NASDAQ:EEIQ) +40%. Bit Digital (NASDAQ:BTBT) +21%. Zeta Global Holdings (NYSE:ZETA) +19%. Synaptogenix (NASDAQ:SNPX) +18%. Marine Petroleum Trust (NASDAQ:MARPS) +16%. Navios Maritime (NYSE:NM) +15%. Biomerica (NASDAQ:BMRA) +13%. Unico Am...
3 Penny Stocks to Watch in October 2021 Penny stocks are on fire right now. And after a few months of volatile trading, we are seeing a return of bullish sentiment among a large range of penny stocks . As a result, many investors are working to align their strategies with the curren...
News, Short Squeeze, Breakout and More Instantly...
Predictive Oncology Inc. Company Name:
POAI Stock Symbol:
NASDAQ Market:
Predictive Oncology Inc. Website:
Predictive Oncology (NASDAQ: POAI) , a leader in AI-driven drug discovery and biologics, today announced the introduction of a new technology designed to express functional and stable G-Protein Coupled Receptors (“GPCRs”). GPCRs are cell surface membrane receptors believed to play a...
Company files expansive intellectual property protection for “Membrane Protein Factory” to produce purified and biologically active membrane proteins for drug development External sources value annual US GPCR market at nearly $3.5 billion in 2022, growing more than 5% annu...
Predictive Oncology (NASDAQ: POAI) , a leader in AI-driven drug discovery and biologics, today announced the availability of its unique 3D cell culture model to advance cancer drug discovery and enable future drug development. More closely mimicking human tissue architecture than traditional 2D a...